| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/12/2004 | WO2004013317A1 A method of obtaining a bacteriophage strain of increased affinity to eukaryotic cells, preparations containing it, and applications of bacteriophages |
| 02/12/2004 | WO2004013309A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 02/12/2004 | WO2004013308A2 Maxs as modifiers of the axin pathway and methods of use |
| 02/12/2004 | WO2004013306A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013275A2 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 02/12/2004 | WO2004013204A2 Polymer extraction methods |
| 02/12/2004 | WO2004013180A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/12/2004 | WO2004013179A1 Conjugate of notch signalling pathway modulators and their use in medical treatment |
| 02/12/2004 | WO2004013174A1 Use of disease-associated gene |
| 02/12/2004 | WO2004013173A1 Novel potassium-dependent sodium-calcium exchanger |
| 02/12/2004 | WO2004013172A2 Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| 02/12/2004 | WO2004013157A2 REDUCING NgR-p75 MEDIATED BY INHIBITION OF AXON REGENERATION |
| 02/12/2004 | WO2004013151A2 Campylobacter glycans and glycopeptides |
| 02/12/2004 | WO2004012855A2 Ethylene glycol monolayer protected nanoparticles |
| 02/12/2004 | WO2004012847A2 Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers |
| 02/12/2004 | WO2004012836A2 Dynamically formed rotors for lock-in amplifier detection |
| 02/12/2004 | WO2004012757A2 Apolipoprotein l-i for the treatment or diagnosis of prypanosomaldiseases |
| 02/12/2004 | WO2004012755A1 Methods for regulating brca1-brca2-containing complex activity |
| 02/12/2004 | WO2004012683A2 Novel druggable regions in set domain proteins and methods of using the same |
| 02/12/2004 | WO2004012675A2 Lipid binding molecules and methods of use |
| 02/12/2004 | WO2004012658A2 Method and device for protein delivery into cells |
| 02/12/2004 | WO2004012588A2 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | WO2004012585A2 Electrophysiology assay methods |
| 02/12/2004 | WO2003102222A3 Continuous-flow enzyme assay with mass spectrometry detection |
| 02/12/2004 | WO2003095984A3 System for measuring material properties from a moving construction vehicle |
| 02/12/2004 | WO2003093307A8 Mycobacterial antigens and uses thereof |
| 02/12/2004 | WO2003093232A3 Feline pancreatic lipase composition and method of preparing and using such composition |
| 02/12/2004 | WO2003091668A3 Monitoring device |
| 02/12/2004 | WO2003090249A3 Sampling probe microarray read out using electrospray mass spectrometry |
| 02/12/2004 | WO2003089456A3 Peptide inhibitors of protein kinase c |
| 02/12/2004 | WO2003087832A3 Diagnosis of carcinoma using raigi polypeptides |
| 02/12/2004 | WO2003077734A3 Methods of diagnosing the presence of trail |
| 02/12/2004 | WO2003077648A3 Methods for the identification of herbicides and the modulation of plant growth |
| 02/12/2004 | WO2003073823A3 PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/12/2004 | WO2003072037A3 High-level production of amyloid-beta peptides from imr-32 cells |
| 02/12/2004 | WO2003072014A3 Minicell compositions and methods |
| 02/12/2004 | WO2003067240A3 Sensor for detecting small concentrations of a target matter |
| 02/12/2004 | WO2003066212A3 Microarray synthesis instrument and method |
| 02/12/2004 | WO2003065979A3 Methods of diagnosis, monitoring and treatment of fertility |
| 02/12/2004 | WO2003064463B1 Pluripotency determining factors and uses thereof |
| 02/12/2004 | WO2003061452A3 Method and system for early detection of infectious diseases or symptoms of bioterrorism attacks |
| 02/12/2004 | WO2003060466A3 Affinity labeling of serine proteases for simultaneous detection of multiple serine protease activity levels |
| 02/12/2004 | WO2003060464A3 A novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein |
| 02/12/2004 | WO2003060142A3 Compositions and methods for controlled release |
| 02/12/2004 | WO2003060040A3 Use of oxygen analysis by gc-aed for control of fischer-tropsch process and product blending |
| 02/12/2004 | WO2003058243A3 Reagent test strip comprising control means and timer means |
| 02/12/2004 | WO2003054516A3 Devices and methods for isolating and detecting specific substances in complex matrices |
| 02/12/2004 | WO2003054506A3 Deuterium-based chemiluminescent 1,2-dioxetanes |
| 02/12/2004 | WO2003054234A9 Pcr based high throughput polypeptide screening |
| 02/12/2004 | WO2003050502A3 Prospective identification and characterization of breast cancer stem cells |
| 02/12/2004 | WO2003050301A3 Susceptibility locus for schizophrenia |
| 02/12/2004 | WO2003050234A3 Method of immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications |
| 02/12/2004 | WO2003049723A3 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 02/12/2004 | WO2003048766A3 Colorimetric artemisinin and artemisinin derivatives assay and assay kit |
| 02/12/2004 | WO2003044524A3 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 02/12/2004 | WO2003044041A3 Alpha-fetoprotein peptides and uses for imaging |
| 02/12/2004 | WO2003042408A3 Sequence variants of the human growth hormone gene and methods for detection |
| 02/12/2004 | WO2003040935A9 Multiport non-blocking high capacity atm and packet switch |
| 02/12/2004 | WO2003040401A9 General screening method for ligand-protein interactions |
| 02/12/2004 | WO2003038726A3 A method for epigenetic knowledge generation |
| 02/12/2004 | WO2003038130A3 Therapeutics and diagnostics for disorders of erythropoiesis |
| 02/12/2004 | WO2003036299A3 Procedure for quantitative determination of viral or bacterial particles having a cholesterol-containing envelope |
| 02/12/2004 | WO2003034996B1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 02/12/2004 | WO2003033670A3 Method for preparation of single chain antibodies |
| 02/12/2004 | WO2003032411A3 Electrochemical cell |
| 02/12/2004 | WO2003025219A3 Method for sequencing nucleic acids |
| 02/12/2004 | WO2003023056A3 Specific markers for multiple sclerosis |
| 02/12/2004 | WO2003021220A3 Assays for inositol phosphates |
| 02/12/2004 | WO2003018776A3 IDENTIFICATION OF THE IκBNS PROTEIN AND ITS PRODUCTS |
| 02/12/2004 | WO2003016887A3 Method for analyzing cellular events in a sample by measuring transmitted and/or reflected electromagnetic test signals in a frequency range from 500 khz to 1000 ghz |
| 02/12/2004 | WO2003014698A3 Biological assay detection method |
| 02/12/2004 | WO2003014382B1 Device for analyzing nucleic acid |
| 02/12/2004 | WO2003014329A3 Modulation of angiogenesis by a-beta peptides |
| 02/12/2004 | WO2003014325A3 Protein design automation for protein libraries |
| 02/12/2004 | WO2003012413A3 Determining water content and droplet size of a water-in-oil emulsion by means of two resonators operating at different frequencies |
| 02/12/2004 | WO2003012041A3 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/12/2004 | WO2003010534A3 Method for quantitative monitoring of a gas injected into a reservoir in particular in a natural environment |
| 02/12/2004 | WO2003008975A3 Biochip and the production method thereof |
| 02/12/2004 | WO2003004677A9 Methods for generating differential profiles by combining data obtained in separate measurements |
| 02/12/2004 | WO2002103363A3 Selection by avidity capture |
| 02/12/2004 | WO2002101057A8 Gene transfer into primate embryonic stem cells using vsv-g pseudo type simian immunodeficiency virus vector |
| 02/12/2004 | WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 02/12/2004 | WO2002096198A3 Methods for the identification of inhibitors of 3-oxo-5-alpha-steroid 4-dehydrogenase expression or activity in plants |
| 02/12/2004 | WO2002090542A8 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 02/12/2004 | WO2002077895A3 Method for epigenetic feature selection |
| 02/12/2004 | WO2002077232A3 Compositions and methods relating to breast specific genes and proteins |
| 02/12/2004 | WO2002069907A8 Anti-neovasculature preparations for cancer |
| 02/12/2004 | WO2002066954A3 Pdz domain interactions and lipid rafts |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002066063A8 Remedies for metabolic bone diseases |
| 02/12/2004 | WO2002064824A3 Oligonucleotide probes used to detect parodontopathogenic bacteria by in situ hybridization |
| 02/12/2004 | WO2002064747A3 Fusion proteins based upon somatostatin receptors |
| 02/12/2004 | WO2002061045A3 Simplified method for indexing and determining the relative concentration of expressed messenger rnas |
| 02/12/2004 | WO2002059609A3 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 02/12/2004 | WO2002059299A3 Expression cloning method |
| 02/12/2004 | WO2002059254A3 Method and device for detecting and controlling the level of biological contaminants in a coating process |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002057411A3 Hydrolase enzymes and their use in kinetic resolution |
| 02/12/2004 | WO2002052046A3 Oligonucleotide transfection screening method |